Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05002738 · ClinicalTrials.gov registry record · Phase 4
Desogestrel-containing COCP Pharmacokinetic Validation Study
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT05002738 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 22 participants.
The verdict
NCT05002738, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study aims to validate prior pharmacokinetic research with combined oral contraceptive pill users that supports utilizing a 24-hour trough concentration as an accurate proxy for the intensive pharmacokinetic parameter of area under the curve (gold standard pharmacokinetics). The original pharmacokinetic studies were performed with a levonorgestrel-containing oral contraceptive pill and we aim to duplicate those findings with a desogestrel-containing oral contraceptive pill.
Interventions
- DRUG Desogestrel and Ethinyl Estradiol Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-09-10 |
| Est. Completion | 2022-11-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05002738
The ClinicalTrials.gov registry entry for NCT05002738 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Desogestrel and Ethinyl Estradiol Tablets is the first listed.
NCT05002738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05002738 about?
NCT05002738 is a clinical study titled "Desogestrel-containing COCP Pharmacokinetic Validation Study". This study aims to validate prior pharmacokinetic research with combined oral contraceptive pill users that supports utilizing a 24-hour trough concentration as an accurate proxy for the intensive pharmacokinetic parameter of area under the curve (gold standard pharmacokinetics). The original pharma...
What is the current status of trial NCT05002738?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2021-09-10. Estimated completion is 2022-11-28.
What interventions are being tested in trial NCT05002738?
The interventions under investigation include: Desogestrel and Ethinyl Estradiol Tablets (DRUG).
Who is sponsoring clinical trial NCT05002738?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.